Steven W H Chau1,2, Oscar W H Wong3, Rema Ramakrishnan4, Sandra S M Chan3, Evelyn K Y Wong5, Pinky Y T Li3, Vanessa Raymont6, Kathryn Elliot7, Shanaya Rathod8, Gayathri Delanerolle6, Peter Phiri7,8. 1. Department of Psychiatry, The Chinese University of Hong Kong, Shatin, Hong Kong. stevenwaihochau@cuhk.edu.hk. 2. Li Chiu Kong Family Sleep Assessment Unit, Department of Psychiatry, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong. stevenwaihochau@cuhk.edu.hk. 3. Department of Psychiatry, The Chinese University of Hong Kong, Shatin, Hong Kong. 4. Nuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, UK. 5. Department of Psychiatry, North District Hospital, Sheung Shui, Hong Kong. 6. Oxford Brain Health Clinical Trials Unit, Department of Psychiatry, University of Oxford, Oxford, UK. 7. Research & Development Department, Tom Rudd Unit, Clinical Trials Facility, Moorgreen Hospital, Southern Health NHS Foundation Trust, Southampton, SO30 3JB, UK. 8. School of Primary Care, Population Sciences and Medical Education, Faculty of Medicine, University of Southampton, Southampton, UK.
Abstract
BACKGROUND: The aims of this systematic review and meta-analysis are to examine the prevalence of adverse mental health outcomes, both short-term and long-term, among SARS patients, healthcare workers and the general public of SARS-affected regions, and to examine the protective and risk factors associated with these mental health outcomes. METHODS: We conducted a systematic search of the literature using databases such as Medline, Pubmed, Embase, PsycInfo, Web of Science Core Collection, CNKI, the National Central Library Online Catalog and dissertation databases to identify studies in the English or Chinese language published between January 2003 to May 2020 which reported psychological distress and mental health morbidities among SARS patients, healthcare workers, and the general public in regions with major SARS outbreaks. RESULTS: The literature search yielded 6984 titles. Screening resulted in 80 papers for the review, 35 of which were included in the meta-analysis. The prevalence of post-recovery probable or clinician-diagnosed anxiety disorder, depressive disorder, and post-traumatic stress disorder (PTSD) among SARS survivors were 19, 20 and 28%, respectively. The prevalence of these outcomes among studies conducted within and beyond 6 months post-discharge was not significantly different. Certain aspects of mental health-related quality of life measures among SARS survivors remained impaired beyond 6 months post-discharge. The prevalence of probable depressive disorder and PTSD among healthcare workers post-SARS were 12 and 11%, respectively. The general public had increased anxiety levels during SARS, but whether there was a clinically significant population-wide mental health impact remained inconclusive. Narrative synthesis revealed occupational exposure to SARS patients and perceived stigmatisation to be risk factors for adverse mental health outcomes among healthcare workers, although causality could not be determined due to the limitations of the studies. CONCLUSIONS: The chronicity of psychiatric morbidities among SARS survivors should alert us to the potential long-term mental health complications of covid-19 patients. Healthcare workers working in high-risk venues should be given adequate mental health support. Stigmatisation against patients and healthcare workers should be explored and addressed. The significant risk of bias and high degree of heterogeneity among included studies limited the certainty of the body of evidence of the review.
BACKGROUND: The aims of this systematic review and meta-analysis are to examine the prevalence of adverse mental health outcomes, both short-term and long-term, among SARSpatients, healthcare workers and the general public of SARS-affected regions, and to examine the protective and risk factors associated with these mental health outcomes. METHODS: We conducted a systematic search of the literature using databases such as Medline, Pubmed, Embase, PsycInfo, Web of Science Core Collection, CNKI, the National Central Library Online Catalog and dissertation databases to identify studies in the English or Chinese language published between January 2003 to May 2020 which reported psychological distress and mental health morbidities among SARSpatients, healthcare workers, and the general public in regions with major SARS outbreaks. RESULTS: The literature search yielded 6984 titles. Screening resulted in 80 papers for the review, 35 of which were included in the meta-analysis. The prevalence of post-recovery probable or clinician-diagnosed anxiety disorder, depressive disorder, and post-traumatic stress disorder (PTSD) among SARS survivors were 19, 20 and 28%, respectively. The prevalence of these outcomes among studies conducted within and beyond 6 months post-discharge was not significantly different. Certain aspects of mental health-related quality of life measures among SARS survivors remained impaired beyond 6 months post-discharge. The prevalence of probable depressive disorder and PTSD among healthcare workers post-SARS were 12 and 11%, respectively. The general public had increased anxiety levels during SARS, but whether there was a clinically significant population-wide mental health impact remained inconclusive. Narrative synthesis revealed occupational exposure to SARSpatients and perceived stigmatisation to be risk factors for adverse mental health outcomes among healthcare workers, although causality could not be determined due to the limitations of the studies. CONCLUSIONS: The chronicity of psychiatric morbidities among SARS survivors should alert us to the potential long-term mental health complications of covid-19patients. Healthcare workers working in high-risk venues should be given adequate mental health support. Stigmatisation against patients and healthcare workers should be explored and addressed. The significant risk of bias and high degree of heterogeneity among included studies limited the certainty of the body of evidence of the review.
Authors: Jonathan P Rogers; Edward Chesney; Dominic Oliver; Thomas A Pollak; Philip McGuire; Paolo Fusar-Poli; Michael S Zandi; Glyn Lewis; Anthony S David Journal: Lancet Psychiatry Date: 2020-05-18 Impact factor: 27.083
Authors: Emily A Holmes; Rory C O'Connor; V Hugh Perry; Irene Tracey; Simon Wessely; Louise Arseneault; Clive Ballard; Helen Christensen; Roxane Cohen Silver; Ian Everall; Tamsin Ford; Ann John; Thomas Kabir; Kate King; Ira Madan; Susan Michie; Andrew K Przybylski; Roz Shafran; Angela Sweeney; Carol M Worthman; Lucy Yardley; Katherine Cowan; Claire Cope; Matthew Hotopf; Ed Bullmore Journal: Lancet Psychiatry Date: 2020-04-15 Impact factor: 27.083
Authors: Dominic T S Lee; Y K Wing; Henry C M Leung; Joseph J Y Sung; Y K Ng; G C Yiu; Ronald Y L Chen; Helen F K Chiu Journal: Clin Infect Dis Date: 2004-09-24 Impact factor: 9.079
Authors: Andrew M Watson; Kevin Biese; Claudia Reardon; Allison Schwarz; Kristin Haraldsdottir; M Alison Brooks; David R Bell; Timothy McGuine Journal: medRxiv Date: 2022-01-11
Authors: Gary Ka-Ki Chung; Carol Strong; Yat-Hang Chan; Roger Yat-Nork Chung; Jung-Sheng Chen; Yi-Hsuan Lin; Ru-Yi Huang; Chung-Ying Lin; Nai-Ying Ko Journal: Front Med (Lausanne) Date: 2022-02-15
Authors: Ernesto González-Mesa; Jesus Salvador Jiménez-López; Marta Blasco-Alonso; Jose Ramon Anderica-Herrero; Daniel Lubián-López Journal: J Clin Med Date: 2021-12-15 Impact factor: 4.241